Effect of Duodenal-Jejunal Bypass Liner on Cardiovascular Risk in Patients with Type 2 Diabetes and Metabolic Syndrome

被引：0
|
作者：
Laubner, Katharina
Roehlen, Natascha
Bettinger, Dominik
Hilger, Hanna
Koenig, Carolin
Krebs, Andreas
Seufert, Jochen
机构：
来源：
DIABETES | 2019年 / 68卷
关键词：
D O I：
10.2337/db19-1-OR
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1-OR
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Endoscopic, duodenal-jejunal bypass liner in obese patients with or without type 2 diabetes lowers incidence of metabolic syndrome and improves cardiovascular risk
    Chilton, R.
    Kim, D.
    de Moura, E. G. H.
    Liao, A.
    Tetreault, J. -C.
    Chiquette, E.
    Escalona, A.
    [J]. DIABETOLOGIA, 2014, 57 : S492 - S492
  • [2] Endoscopic Duodenal-Jejunal Bypass Liner Rapidly Improves Type 2 Diabetes
    de Jonge, Charlotte
    Rensen, Sander S.
    Verdam, Froukje J.
    Vincent, Royce P.
    Bloom, Steve R.
    Buurman, Wim A.
    le Roux, Carel W.
    Schaper, Nicolaas C.
    Bouvy, Nicole D.
    Greve, Jan Willem M.
    [J]. OBESITY SURGERY, 2013, 23 (09) : 1354 - 1360
  • [3] Duodenal-Jejunal Bypass Liner (DJBL) Improves Cardiovascular Risk Biomarkers and Predicted 4-Year Risk of Major CV Events in Patients with Type 2 Diabetes and Metabolic Syndrome
    Natascha Roehlen
    Katharina Laubner
    Dominik Bettinger
    Henning Schwacha
    Hanna Hilger
    Carolin Koenig
    Dirk Grueninger
    Andreas Krebs
    Jochen Seufert
    [J]. Obesity Surgery, 2020, 30 : 1200 - 1210
  • [4] Duodenal-Jejunal Bypass Liner (DJBL) Improves Cardiovascular Risk Biomarkers and Predicted 4-Year Risk of Major CV Events in Patients with Type 2 Diabetes and Metabolic Syndrome
    Roehlen, Natascha
    Laubner, Katharina
    Bettinger, Dominik
    Schwacha, Henning
    Hilger, Hanna
    Koenig, Carolin
    Grueninger, Dirk
    Krebs, Andreas
    Seufert, Jochen
    [J]. OBESITY SURGERY, 2020, 30 (04) : 1200 - 1210
  • [5] Duodenal-Jejunal Bypass Liner to Treat Type 2 Diabetes Mellitus in Morbidly Obese Patients
    Rodrigo Muñoz
    Alex Escalona
    [J]. Current Cardiology Reports, 2014, 16
  • [6] Duodenal-Jejunal Bypass Liner to Treat Type 2 Diabetes Mellitusin Morbidly Obese Patients
    Munoz, Rodrigo
    Escalona, Alex
    [J]. CURRENT CARDIOLOGY REPORTS, 2014, 16 (03)
  • [7] ENDOSCOPICALLY DELIVERED DUODENAL-JEJUNAL BYPASS LINER TO TREAT TYPE 2 DIABETES IN OBESE PATIENTS
    Curcio, G.
    Casu, A.
    Traina, M.
    Colanino, M. Ziino
    Tuzzolino, F.
    Vizzini, G.
    Gridelli, B.
    [J]. DIGESTIVE AND LIVER DISEASE, 2014, 46 : S143 - S143
  • [8] Improvement of Type 2 Diabetes after Implantation of a Duodenal-Jejunal Bypass Liner in Obese Patients
    Betzel, B.
    Koehestanie, P.
    Dogan, K.
    Janssen, I.
    Wahab, P.
    Berends, F.
    de Boer, H.
    [J]. OBESITY SURGERY, 2013, 23 (08) : 1179 - 1180
  • [9] Endoscopic Duodenal-Jejunal Bypass Liner (EndoBarrier®) for the treatment of type 2 diabetes mellitus
    Laubner, K.
    Perakakis, N.
    Potasso, L.
    Schwacha, H.
    Seufert, J.
    [J]. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2014, 122 (03)
  • [10] Impact of duodenal-jejunal bypass liner (DJBL) on NAFLD in patients with obesity and type 2 diabetes mellitus
    Roehlen, Natascha
    Laubner, Katharina
    Nicolaus, Leonard
    Schwacha, Henning
    Bettinger, Dominik
    Krebs, Andreas
    Thimme, Robert
    Seufert, Jochen
    [J]. NUTRITION, 2022, 103-104
12345